Skip to main content

Table 1 Anthropometrics and baseline descriptives in Turner syndrome and age and gender-matched controls, and Turner syndrome without CoA (Coarctation of Aorta) and Turner syndrome with CoA

From: Impaired aortic distensibility and elevated central blood pressure in Turner Syndrome: a cardiovascular magnetic resonance study

 

Turner Syndrome (n = 57)

Controls (n = 36)

P value†

Turner Syndrome without CoA (n = 49)

Turner Syndrome with CoA (n = 8)

P value‡

Age [years]

46.1 ± 10.2

46.0 ± 12.9

0.9

45.9 ± 10.2

47.1 ± 10.3

0.8

Weight [kg]

62.5 ± 14.6

71.2 ± 13.5

0.01

61.8 ± 14.3

66.9 ± 16.4

0.4

Height [cm]

147.2 ± 6.7

169.3 ± 6.4

< 0.001

147.0 ± 7.1

148.1 ± 3.8

0.7

Body Mass Index [kg/m2]

28.9 ± 6.7

24.9 ± 4.6

0.001

28.6 ± 6.6

30.5 ± 7.3

0.5

Body Surface Area

1.5 ± 0.2

1.8 ± 0.2

< 0.001

1.5 ± 0.2

1.6 ± 0.2

0.4

24 h systolic Blood Pressure [mmHg]a

117.9 ± 12.7

115.2 ± 10.7

0.3

117.5 ± 13.0

120.1 ± 11.6

0.6

24 h diastolic Blood Pressure [mmHg]a

74.5 ± 10.2

71.7 ± 6.6

0.1

74.3 ± 9.9

75.3 ± 12.5

0.8

Day-time systolic Blood Pressure [mmHg]a

123.4 ± 13.5

121.4 ± 10.6

0.5

122.8 ± 13.5

126.6 ± 14.2

0.5

Day-time diastolic Blood Pressure [mmHg]a

78.6 ± 11.4

76.9 ± 6.5

0.4

78.3 ± 10.7

80.3 ± 15.1

0.7

Night-time systolic Blood Pressure [mmHg]a

106.4 ± 11.9

103.3 ± 11.1

0.2

106.4 ± 12.6

106.4 ± 8.2

1

Night-time diastolic Blood Pressure [mmHg]a

66.2 ± 8.6

61.5 ± 7.1

0.01

66.3 ± 8.7

65.6 ± 8.9

0.9

Systolic Blood pressure, Sphygmocor (right)

121.3 ± 12.9

119.4 ± 13.8

0.5

120.7 ± 13.3

125.1 ± 10.0

0.4

Diastolic Blood pressure, Sphygmocor (right)

77.6 ± 9.8

72.1 ± 8.8

0.007

77.3 ± 10.1

79.4 ± 8.8

0.6

Systolic Blood pressure, Sphygmocor (left)

118.2 ± 13.8

118.4 ± 14.0

1.0

117.8 ± 14.3

120.6 ± 10.1

0.6

Diastolic Blood pressure, Sphygmocor (left)

76.3 ± 9.4

71.3 ± 9.0

0.01

76.2 ± 9.4

77.1 ± 10.3

0.8

Low Density Lipids [mmol/L]b

2.6 ± 0.8

2.6 ± 0.9

0.9

2.7 ± 0.8

2.6 ± 0.9

0.9

High Density Lipids [mmol/L]b

1.8 ± 0.6

1.8 ± 0.5

0.8

1.8 ± 0.5

1.7 ± 0.7

0.9

Triglycerides [mmol/L]b

1.1 ± 0.7

1.1 ± 1.0

0.8

1.1 ± 0.6

1.4 ± 0.9

0.2

HbA1C [mmol/mol]b

36.0 [28.0–70.0]

35.5 [26.0–48.0]

0.2

36.0 [28.0–62.0]

38.4 [31.0–70.0]

0.3

Bicuspid aortic valvec

19% (11/57)

0% (0/36)

0.006

12% (6/49)

63% (5/8)

0.005

Coarctation of the aortac

14% (8/57)

0% (0/36)

0.02

0% (0/49)

100% (8/8)

< 0.001

Elongated transverse aortac

46% (26/57)

0% (0/36)

< 0.001

43% (21/49)

63% (5/8)

0.3

Type 2 Diabetesc

18% (10/57)

0% (0/36)

0.006

12% (6/49)

50% (4/8)

0.03

Statinsc

16% (9/57)

3% (1/36)

0.08

14% (7/49)

25% (2/8)

0.4

Aspirinc

5% (3/57)

0% (0/36)

0.3

6% (3/49)

0% (0/8)

0.6

Antihypertensivesc

49% (28/57)

14% (5/36)

< 0.001

49% (24/49)

50% (4/8)

0.6

Hormone replacement treatmentc

72% (41/57)

3% (1/36)

< 0.001

73% (36/49)

63% (5/8)

0.4

  1. Blood pressure marked with SphygmoCor where used to calibrated measurements done with the SphygmoCor equipment
  2. afor Turner syndrome: n = 50, for controls: n = 34. For Turner syndrome without CoA: n = 42
  3. bfor Turner syndrome: n = 56, for controls: n = 36. For Turner syndrome without CoA: n = 48
  4. cFisher’s Exact Test
  5. †: p-value for the comparison between the entire TS cohort and controls
  6. ‡: p-value for the comparison between TS without CoA and TS with CoA